Rocket


News + Filings
Transactions





Esposito Pamela

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/22/2023Replimune Group, Inc.REPLSaleCommon Stock18.6k$20.01$372.2k 08/22/2023
08/22/2023Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)13.6k$3.30$44.9k 08/22/2023
08/22/2023Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)5k$15.50$77.5k 08/22/2023
08/11/2023Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)1.4k$3.30$4.6k 08/11/2023
08/11/2023Replimune Group, Inc.REPLSaleCommon Stock1.4k$20.00$28k 08/11/2023
07/10/2023Replimune Group, Inc.REPLSaleCommon Stock17.9k$21.63$387.7k 07/10/2023
07/10/2023Replimune Group, Inc.REPLSaleCommon Stock2.1k$21.12$43.9k 07/10/2023
07/10/2023Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)15k$3.30$49.5k 07/10/2023
07/10/2023Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)5k$15.50$77.5k 07/10/2023
05/16/2023Replimune Group, Inc.REPLSaleCommon Stock6k$18.05$107.7k 05/16/2023
04/01/2023Replimune Group, Inc.REPLGrantCommon Stock40k$0.00$0 04/01/2023
04/01/2023Replimune Group, Inc.REPLGrantEmployee Stock Option (right to buy)60k$17.66$1.1M 04/01/2023
12/09/2022Replimune Group, Inc.REPLSaleCommon Stock15k$25.03$375.4k 12/09/2022
12/09/2022Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)15k$1.01$15.2k 12/09/2022
06/15/2022Kymera Therapeutics, Inc. GrantStock Option (Right to Buy)12k$14.18$170.2k 06/15/2022
04/01/2022Replimune Group, Inc.REPLGrantEmployee Stock Option (right to buy)34.1k$18.26$623.1k 04/01/2022
04/01/2022Replimune Group, Inc.REPLGrantCommon Stock22.8k$0.00$0 04/01/2022
08/05/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)25.8k$15.50$399.9k 08/04/2021
08/05/2021Replimune Group, Inc.REPLSaleCommon Stock25.8k$35.09$905.3k 08/04/2021
08/04/2021Replimune Group, Inc.REPLSaleCommon Stock4.2k$35.00$147k 08/04/2021
08/04/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)4.2k$15.50$65.1k 08/04/2021
07/15/2021Replimune Group, Inc.REPLSaleCommon Stock4.6k$33.37$153.5k 07/15/2021
07/15/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)4.6k$1.01$4.6k 07/15/2021
06/16/2021Kymera Therapeutics, Inc. GrantStock Option (Right to Buy)20.1k$49.10$985.1k 06/16/2021
04/01/2021Replimune Group, Inc.REPLGrantEmployee Stock Option (right to buy)51.2k$31.58$1.6M 04/01/2021
04/01/2021Replimune Group, Inc.REPLGrantCommon Stock34.2k$0.00$0 04/01/2021
01/19/2021Replimune Group, Inc.REPLSaleCommon Stock600$43.24$25.9k 01/14/2021
01/19/2021Replimune Group, Inc.REPLSaleCommon Stock5.1k$42.38$217.3k 01/14/2021
01/19/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)5.7k$1.01$5.8k 01/14/2021
01/19/2021Replimune Group, Inc.REPLSaleCommon Stock600$43.24$25.9k 01/14/2021
01/19/2021Replimune Group, Inc.REPLSaleCommon Stock5.1k$42.38$217.3k 01/14/2021
01/19/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)5.7k$1.01$5.8k 01/14/2021
01/15/2021Replimune Group, Inc.REPLSaleCommon Stock29.3k$43.58$1.3M 01/14/2021
01/15/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)29.3k$1.01$29.6k 01/14/2021
01/15/2021Replimune Group, Inc.REPLExerciseEmployee Stock Option (right to buy)29.3k$1.01$29.6k 01/14/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy